Frequencies for first 10,000 rows of lit_ref variable in demo2017q1 dataset : Literature Reference | Freq. Percent Cum. ----------------------------------------+----------------------------------- | 9,408 94.08 94.08 , ANDO S, HONDA N, NOGUCHI H, MAEMORI.. | 1 0.01 94.09 , ARAUJO C, MARTINS-COELHO G, AND ISE.. | 1 0.01 94.10 , BAGANZ L., KEKOW J., BUSSMANN A., K.. | 1 0.01 94.11 , BAINS M, PARK D, JANJIGIAN Y, RUSCH.. | 1 0.01 94.12 , BRONOWICKI J, DE LEDINGHEN V, HEZOD.. | 1 0.01 94.13 , CHAU I, PECKITT C, PATEL B, DE CAST.. | 4 0.04 94.17 , CHAU I, PECKITT C, PATEL B, DE CAST.. | 1 0.01 94.18 , CHERIPELLI B, KALLADKA D, MORETON F.. | 3 0.03 94.21 , CHERIPELLI B, KALLADKA D, MORETON F.. | 1 0.01 94.22 , CHERIPELLI B, KALLADKA D, MORETON F.. | 1 0.01 94.23 , DAKHIL S, SALEH M, PIPERDI B, CLINE.. | 1 0.01 94.24 , DEMERET S, BOLGERT F, EYMARD B, LAF.. | 1 0.01 94.25 , DENISOVA R, VALIEVA S, BZAROVA T, S.. | 1 0.01 94.26 , DESJARDINS A, REARDON D, PETERS K, .. | 1 0.01 94.27 , ET AL A CASE OF CROHN^S DISEASE AFT.. | 1 0.01 94.28 , FOUGEROU C, DE LEDINGHEN V, DUVOUX .. | 1 0.01 94.29 , GEORGANTOPOULOS P, RAO G, OLIVER SA.. | 1 0.01 94.30 , GOPAL A, PRESS O, MALONEY D, MAWAD .. | 1 0.01 94.31 , GRAF D, ATTWOOD K., MUNTEANU M AND .. | 1 0.01 94.32 , GRAF D, MUNTEANU M AND CZUCZMAN M 1.. | 2 0.02 94.34 , GRUNWALD J, DANIEL E, HUANG J, YING.. | 1 0.01 94.35 , GUNASEKARA M, LIANWEA C, MARCUS R, .. | 1 0.01 94.36 , HALLER D, MYKULOWYCZ K, ROSEN M, SO.. | 1 0.01 94.37 , HONG F, LI H, GORDON L, GASCOYNE R,.. | 1 0.01 94.38 , HORGAN D, HOLLINGWORTH S, GRAHAM J,.. | 1 0.01 94.39 , HORGAN D, HOLLINGWORTH S, GRAHAM J,.. | 2 0.02 94.41 , HORGAN D, HOLLINGWORTH S, GRAHAM J,.. | 2 0.02 94.43 , INDRAKANTI D, SPECKS U, STONE J, HO.. | 1 0.01 94.44 , INNOCENTI I, AUTORE F, PASQUALE R, .. | 1 0.01 94.45 , ISKAS M, STALIKA E, KARYPIDOU M, TA.. | 2 0.02 94.47 , IZZO F, PALAIA R, DI GIACOMO R, PIC.. | 1 0.01 94.48 , JOVIC N, TADIC B, KRAVLJANAC D AND .. | 1 0.01 94.49 , KANG W, LIM D, PARK J, PARK Y, LIM.. | 1 0.01 94.50 , KLINE J, BAUMAN J, GARDNER O, JONAK.. | 1 0.01 94.51 , LAMONICA D, GAYLOR S, BUSH L, NADOL.. | 1 0.01 94.52 , LAMONICA D, GAYLOR S, BUSH L, NADOL.. | 1 0.01 94.53 , LAPLANT, B. MACON, W R. REEDER, C B.. | 1 0.01 94.54 , LAWRENCE M, AND BORISH L FATAL ASEP.. | 1 0.01 94.55 , LFRASSOLDATI A, BOTTINI A, CAGOSSI .. | 1 0.01 94.56 , LIM JK, KUO A, DI BISCEGLIE AM, GAL.. | 1 0.01 94.57 , LOGANATHAN P, KOONTZ D, QI Z, REED .. | 1 0.01 94.58 , MAHONEY M, LOUI W, ROBERTS L, SMYRK.. | 1 0.01 94.59 , MASUHARA H, KURIHARA A, SHIOKAWA H,.. | 1 0.01 94.60 , MONTAGNA E, PALAZZO A, MAISONNEUVE .. | 1 0.01 94.61 , NAKAGISHI Y, KASAI K, YAMASAKI Y, M.. | 1 0.01 94.62 , OKADA M, MIYAZONO A, SATO M, ET AL... | 1 0.01 94.63 , PITCHER B, JUNG S, BARTLETT N, WAGN.. | 1 0.01 94.64 , PITCHER B, JUNG S, BARTLETT N, WAGN.. | 1 0.01 94.65 , QIAN W, VALLE J, TALBOT D, CUNNINGH.. | 1 0.01 94.66 , SAKUMURA M, TAJIRI K, MIWA S, NAGAT.. | 1 0.01 94.67 , SALVATORE L, BARBARA C, ALLEGRINI G.. | 1 0.01 94.68 , SAURA C, HENDERSON C, LIN N, MAHTAN.. | 1 0.01 94.69 , SCHNEEWEISS A, LOIBL S, UNTCH M, PA.. | 1 0.01 94.70 , SEISLER D, FOSTER J, SLOAN J, LAFKY.. | 1 0.01 94.71 , SHEN S, BUNCH P, STRAUGHN M, TORGUE.. | 1 0.01 94.72 , SHEN S, BUNCH P, STRAUGHN M, TORGUE.. | 1 0.01 94.73 , SHIBA H, NAKASEKO Y, ET AL A LETHAL.. | 1 0.01 94.74 , SISK R, TZU J, ALBINI T, DAVIS J, M.. | 1 0.01 94.75 , SISK R, TZU J, ALBINI T, DAVIS J, M.. | 1 0.01 94.76 , SMYTH E, LOEHR A, HARDING T, RAPONI.. | 1 0.01 94.77 , SMYTH E, LOEHR A, HARDING T, RAPONI.. | 1 0.01 94.78 , SMYTH E, LOEHR A, HARDING T, RAPONI.. | 1 0.01 94.79 , SMYTH E, LOEHR A, HARDING T, RAPONI.. | 1 0.01 94.80 , SMYTH E, LOEHR A, HARDING T, RAPONI.. | 2 0.02 94.82 , SPRATT, N. BIVARD, A. CAMPBELL, B. .. | 1 0.01 94.83 , SPRATT, N. BIVARD, A. CAMPBELL, B. .. | 1 0.01 94.84 , SPRATT, N. BIVARD, A. CAMPBELL, B. .. | 1 0.01 94.85 , SPRATT, N. BIVARD, A. CAMPBELL, B. .. | 1 0.01 94.86 , SPRATT, N. BIVARD, A. CAMPBELL, B. .. | 1 0.01 94.87 , TARELLA C, GIANNI A, LADETTO M, BAR.. | 1 0.01 94.88 , UMESHITA K AND UEMOTO S. OPTIMAL DO.. | 1 0.01 94.89 , VALLADARES M, GEA S AND LOPEZ-MARTI.. | 1 0.01 94.90 , VAN WERKHOVEN E, MANDJES I, SCHOT M.. | 1 0.01 94.91 , VINCENT-SALOMON A, PAGET-BAILLY S, .. | 1 0.01 94.92 , WIENAND W, PURTSKHVANIDZE K, ROIDER.. | 1 0.01 94.93 , WIENAND W, PURTSKHVANIDZE K, ROIDER.. | 1 0.01 94.94 , WILKS S, BRUFSKY A, O^SHAUGHNESSY J.. | 1 0.01 94.95 A. ANASTASILAKIS, P. MAKRAS, T. ANAST.. | 1 0.01 94.96 A. ULLAH K. ABDULNABI, P. GALLAEHER,.. | 1 0.01 94.97 ABE M. A CASE OF RHEUMATOID ARTHRITIS.. | 1 0.01 94.98 ABRAHAM A, RUBIN M, ACCILI D, BILEZIK.. | 1 0.01 94.99 ADACHI A, KOMINE M, HIRAVO T, TSUDA H.. | 1 0.01 95.00 ADACHI A. LETTERS TO THE EDITOR CASE .. | 1 0.01 95.01 ADAMEK R, WILCZEK L, KRUPINSKI B. SEV.. | 1 0.01 95.02 AGUILAR S, LOUIS C, HICKS J, ZAGE P, .. | 1 0.01 95.03 AKBOGA M,AKYEL A,AYDOGDU S. ACUTE COR.. | 1 0.01 95.04 AKBOGA MK, AKYEL A, AYDOGDU S. ACUTE .. | 1 0.01 95.05 AKHTAR, J., MORATO D., BRANT E., YANT.. | 1 0.01 95.06 AKOGLU G. DOCETAXEL-INDUCED PALMOPLAN.. | 1 0.01 95.07 AL MAASHARI R, HAMODAT MM. METHOTREXA.. | 1 0.01 95.08 AL MAASHHARI R, HAMODAT M. METHOTREXA.. | 1 0.01 95.09 AL-KHALISY HM, NIKIFOROV I, MANSOORA .. | 1 0.01 95.10 ALHURAIJI A. SOLID TUMORS IN PATIENTS.. | 1 0.01 95.11 ALHURAIJI A. SOLID TUMORS IN PATIENTS.. | 1 0.01 95.12 ALMEIDA J,LOPES A,CAMPOS MELO A,PEREI.. | 1 0.01 95.13 ALSERRI A AND TULANDI T. INADVERTENT .. | 1 0.01 95.14 ALZEER AH, AL OTAIR HA, KHURSHID SM, .. | 1 0.01 95.15 AMMORI BJ. LAPAROSCOPIC PANCREAS-PRES.. | 1 0.01 95.16 AMODEO G, MAINA G, ROSSO G, VIOLA M, .. | 1 0.01 95.17 ANDRIANA N, PULUNGAN AB, TRIDJAJA B. .. | 2 0.02 95.19 ANTIBACTERIALS/LISINOPRIL. REACTION W.. | 1 0.01 95.20 APURI S. EVIDENCE FOR SELECTIVE BENEF.. | 1 0.01 95.21 ARAUJO C, RESENDE C, PARDAL F, BRITO .. | 1 0.01 95.22 ARUN KUMAR K, KAR R, JACOB SE, BASU D.. | 1 0.01 95.23 AYAN, M.. CASE OF ACQUIRED OR PSEUDO-.. | 1 0.01 95.24 AYED A, MACON W. LENALIDOMIDE PLUS R-.. | 1 0.01 95.25 AZAD N, ADKINS D. COMBINATION EPIGENE.. | 1 0.01 95.26 B BUTCHER. EARLY TREATMENT INTENSIFIC.. | 1 0.01 95.27 B N. XXII SEDENE CONGRESS. 2015;. | 1 0.01 95.28 BEK S, KOC G, GENC G, GOKCIL Z. THE F.. | 7 0.07 95.35 BELLIZZI A, ANZIVINO E, FERRARI F, DI.. | 1 0.01 95.36 BENABBAD I, ROSILIO M, CHILD C, CAREL.. | 1 0.01 95.37 BENWELL N, BOAN P, RABY E, MCGETTIGAN.. | 1 0.01 95.38 BERGHOF AT AND JOSEPH C. IMATINIB MES.. | 1 0.01 95.39 BERKOVA M, BERKA Z, TOPINKOVA E. ARRH.. | 2 0.02 95.41 BEUKELMAN T, XIE F, CHEN L, BADDLEY J.. | 1 0.01 95.42 BEZINOVER D, SUGINO S, IMAMURA-KAWASA.. | 1 0.01 95.43 BHIMMA R, NAICKER E, RAMDIAL PK. MYCO.. | 1 0.01 95.44 BLANQUISETT AH, VICENT CH, GREGORI JG.. | 1 0.01 95.45 BLASCO MORENTE G, TERCEDOR SANCHEZ J,.. | 1 0.01 95.46 BOISDRON-CELLE M, CAPITAIN O, FAROUX .. | 1 0.01 95.47 BOISDRON-CELLE, M.. PREVENTION OF 5-F.. | 1 0.01 95.48 BORRAS-BLASCO J, FERNANDEZ-MARTINEZ S.. | 1 0.01 95.49 BRESHEARS JD, IVAN ME, COTTER JA, BOL.. | 1 0.01 95.50 BRUNO OD, JUAREZ-ALLEN L, CHRISTIANSE.. | 4 0.04 95.54 BS, BJ, GH, ON. LONG-TERM VAPTAN TREA.. | 1 0.01 95.55 BURKE MJ, BROWN P, SPOSTO R, GORE L, .. | 1 0.01 95.56 BUSARDO F. THE NEVER-ENDING PUBLIC HE.. | 1 0.01 95.57 BUSARDO, F.. THE NEVER-ENDING PUBLIC .. | 1 0.01 95.58 BUSSE W, MORGAN W, GERGEN P, MITCHELL.. | 1 0.01 95.59 C. PHILIPPONNET, JL. KEMENY, J. ANIOR.. | 1 0.01 95.60 CADRANEL J, GERVAIS R, WISLEZ M, MERL.. | 1 0.01 95.61 CALF H,MEIJER E,TAKENS L,HOBBBLET H,J.. | 1 0.01 95.62 CALVO M., GUCALP R., HONG S., CURTIS .. | 1 0.01 95.63 CANO-MOLLINEDO M. SERIOUS ADVERSE REA.. | 1 0.01 95.64 CANO-MOLLINEDO MM, RODRIGUEZ DEL RIO .. | 1 0.01 95.65 CAPRIA S, DE ANGELIS F, GENTILE G, TR.. | 1 0.01 95.66 CARMI PS, BARRY C, RODRIGUES J, MEHTA.. | 1 0.01 95.67 CARREIRO FT, COELHO SC, HORTA AB, SA .. | 1 0.01 95.68 CARROLL A, MOLONEY S, MURPHY NP. HYPE.. | 1 0.01 95.69 CAVAILHES A, INGEN-HOUSZ-ORO S, DJENN.. | 1 0.01 95.70 CAVALLARI M, CICCONE M, CAVAZZINI F, .. | 1 0.01 95.71 CAVANAUGH Z, NAUT ER. ACETAMINOPHEN-I.. | 1 0.01 95.72 CHAMBERLAIN MC, COLMAN H, KIM BT, RAI.. | 1 0.01 95.73 CHANG CHIEN GC, MCCORMICK Z, ARAUJO M.. | 1 0.01 95.74 CHAUDHURI K, PHILLIPS CW, CHAUDHURI S.. | 1 0.01 95.75 CHEGGOURA M, GAMBRELLEB J. DECOLLEMEN.. | 1 0.01 95.76 CHEGGOURA M, GAMBRELLEB J. DECOLLEMEN.. | 1 0.01 95.77 CHEGONDI M, RASZYNSKI A, TOTAPALLY BR.. | 1 0.01 95.78 CHIKTHIMMAH V, CHATTINGTON P. AN UNUS.. | 1 0.01 95.79 CHILTON AP, HUSSAIN T, ELIAS E. PARAC.. | 1 0.01 95.80 CHISBERT V, ZAVALA S, LLOPIS JE, SIVE.. | 1 0.01 95.81 CHOUCHANA, L.. NEUROVASCULAR ADVERSE .. | 1 0.01 95.82 CIRUELOS E, APELLANIZ-RUIZ M, CANTOS .. | 1 0.01 95.83 CIVARDI G, ZANLARI L, BASSI E, ZANGRA.. | 1 0.01 95.84 COBAN H. RESPIRATORY ARREST DUE TO NI.. | 1 0.01 95.85 COHEN PR. THE ^KNIFE-CUT SIGN^ REVISI.. | 1 0.01 95.86 CONTE P, CAMPONE M, PRONZATO P, AMADO.. | 1 0.01 95.87 CONWAY R, O^NEILL L, O^FLYNN E, MCCAR.. | 1 0.01 95.88 COPE, J.. MEDICATION EXPOSURES AND SU.. | 1 0.01 95.89 COPETTI R, PERIC D, AMORE G, GUGLIELM.. | 1 0.01 95.90 COPLAN PM, SESSLER NE, KALE H, HARIKI.. | 1 0.01 95.91 CRITTENDEN NE, BUCHANAN LA, PINKSTON .. | 1 0.01 95.92 CUMPSTON, K.. ADJUNCTIVE USE OF LOW-D.. | 1 0.01 95.93 CZUL F, SCHIFF E, PEYTON A, LEVY C, .. | 1 0.01 95.94 DAOUED F, ANGOULVANT T, MAMMOU S, PAI.. | 1 0.01 95.95 DARCY A. KRUEGER MD, PHD. LONG-TERM T.. | 1 0.01 95.96 DATE E. AN AUTOPSY CASE OF THYROID CA.. | 1 0.01 95.97 DAY, M. O.. VARIOUS DRUGS. REACTIONS .. | 1 0.01 95.98 DE LORENZO-PINTO A, PINILLA LLORENTE .. | 1 0.01 95.99 DEBSKA-SZMICH S, CZERNEK U, KRAKOWSKA.. | 1 0.01 96.00 DELANEY S, NEUMAN G, ITO S, COLANTONI.. | 1 0.01 96.01 DEMIRTAS L, AKBAS EM, DEGIRMENCI H, G.. | 1 0.01 96.02 DIAMANT T, ANDREW B, KRISTIAN R, TSEN.. | 1 0.01 96.03 DIARRA M, KHABBAL Y, BOUJRAF S, AJDI .. | 1 0.01 96.04 DIEJOMAOH MF, BELLO Z, JASSAR WA, JIR.. | 2 0.02 96.06 DIXIT S, NAMDEO M, AZAD S. VALPROATE .. | 1 0.01 96.07 DONATI M, PAOLINO G, MUSCARDIN L, PAN.. | 1 0.01 96.08 DRAUPADI B. TALREJA. SEVERE HYPOCALCE.. | 1 0.01 96.09 DURANT C, SIMOENS G, PIAGNERELLI M, B.. | 1 0.01 96.10 DUTTA H, SENGUPTA S, TIWARI RR. OLANZ.. | 1 0.01 96.11 EL-ASMAR J, GONZALEZ R, BOOKOUT R, MI.. | 1 0.01 96.12 EL-ASMAR, J.. CLOTRIMAZOLE TROCHES IN.. | 1 0.01 96.13 ERYILMAZ M, MUTLU H, SALIM D, MUSRI F.. | 1 0.01 96.14 ESPAY A, RICCIARDI L, FASANO A. RESPO.. | 1 0.01 96.15 ESTEBAN-JIMENEZ O, NAVARRO-PEMAN C, G.. | 1 0.01 96.16 FAITH WR, HOANG MP, KROSHINSKY D, SM.. | 1 0.01 96.17 FALCONE R, ROBERTO M, D ANTONIO C, RO.. | 1 0.01 96.18 FERNANDEZ A, FERNANDEZ A SARCOIDOSIS .. | 1 0.01 96.19 FEVERY B, THYS K, VAN ROSSEM E, VERBI.. | 1 0.01 96.20 FLEMING P, DRAZEK L, SHAW JC. HYPERGL.. | 1 0.01 96.21 FOLZENLOGEN D. A CASE OF ATORVASTATIN.. | 1 0.01 96.22 FONTANA RJ, BROWN JR RS, MORENO-ZAMOR.. | 1 0.01 96.23 FORBUSH J. OMALIZUMAB AND ALLERGEN IM.. | 1 0.01 96.24 FU P, PENNELL N, SHARMA N, YI Q, DOWL.. | 1 0.01 96.25 FUJITA M, GOTO T, UCHIDA K, SAIKI S, .. | 1 0.01 96.26 FUNG SC, WYSSUSEK KH. HYPERTHYROIDISM.. | 1 0.01 96.27 GAEBEL W. RELAPSE PREVENTION WITH RIS.. | 1 0.01 96.28 GARG Y, GORE R, JAIN S, KUMAR A. A RA.. | 1 0.01 96.29 GAROFALO S, AIDALA E, TERUZZI E, PACE.. | 1 0.01 96.30 GEORGE MICHALOPOULOS, SPYRIDON VRAKAS.. | 1 0.01 96.31 GOKITA M, YAMADA Y, YOU N. {CLINICAL .. | 1 0.01 96.32 GOLOMB BA, KOSLIK HJ, REDD AJ. FLUORO.. | 1 0.01 96.33 GONZALEZ DIAZ, C.. DRESS INDUCED BY P.. | 1 0.01 96.34 GRACIA-TELLO B, EZEONYEJI A, ISENBERG.. | 1 0.01 96.35 GRAHAMMER F, FISCHER K-G. PULMONARY I.. | 1 0.01 96.36 GRAY D, FOO D. REVERSIBLE MYOCLONUS, .. | 1 0.01 96.37 GRIECO A. SEVERE CHOLESTATIC HEPATITI.. | 1 0.01 96.38 GRIGULL L, KUEHLKE O, BEILKEN A, SAND.. | 2 0.02 96.40 GRIGULL L, KUEHLKE O, BEILKEN A, SAND.. | 1 0.01 96.41 GRUENWALD, V.. TEMHEAD: A SINGLE-ARM .. | 2 0.02 96.43 GUNBATAR H, DEMIR C, KARA E, ESEN R, .. | 1 0.01 96.44 GURBUZ AS, GODE F, OZCIMEN N, ISIK AZ.. | 3 0.03 96.47 HALDAR A, SAHA S, GUHA G. TWO RARE CA.. | 1 0.01 96.48 HALDAR A, SAHA S, GUHA G. TWO RARE CA.. | 1 0.01 96.49 HALDAR A, SAHA S, GUHA G.. TWO RARE C.. | 1 0.01 96.50 HAMADA T, AOYAMA Y, SHIRAFUJI Y, IWAT.. | 1 0.01 96.51 HAMADA YUTO ET AL. PULMONARY TUBERCUL.. | 1 0.01 96.52 HAMANO T, NAKANO C. ET AL.. IS DENOSM.. | 1 0.01 96.53 HAMMOND M, CHAC?N J, ANT?N A, PLAZAOL.. | 1 0.01 96.54 HARAGUCHI M. ?ET AL. OIL-BASED CONTRA.. | 1 0.01 96.55 HASHIMOTO A. COMBINATION CHEMOTHERAPY.. | 1 0.01 96.56 HATSUSE M, FUCHIDA S, OKANO A, MURAKA.. | 1 0.01 96.57 HAYASHI S, MARUOKA S, TAKAHASHI N, HA.. | 1 0.01 96.58 HEROLD M. BIOREG: SUCCESSFUL BIOLOGIC.. | 1 0.01 96.59 HIDETOSHI T, ET AL. A CASE OF MPPE CO.. | 1 0.01 96.60 HIRANO T. CLINICAL INVESTIGATION EFFE.. | 1 0.01 96.61 HIRASHIMA Y, ET AL. A CASE OF INVASIV.. | 1 0.01 96.62 HOLKOVA B. A PHASE 1 STUDY OF BORTEZO.. | 1 0.01 96.63 HORIKOSHI S, OIKAWA O, OTSUKI T, OZAW.. | 1 0.01 96.64 HOURIGAN CS, FORDE PM, AMBINDER RF, G.. | 1 0.01 96.65 HSU S-T, WANG R-C, LU C-H, KE Y-M, CH.. | 1 0.01 96.66 HUIZENGA T, NEWSOM E, FAKHOURI T AND .. | 1 0.01 96.67 IKEDA K, CONNORS R, LEE D, KHANDJI A,.. | 5 0.05 96.72 IMANO T, NAGASAKI G, SHIMIZU K, ABE K.. | 1 0.01 96.73 INAMURA S, ITO H, KOMATSU K, KAWANO M.. | 1 0.01 96.74 ISHIHARA, A., ET AL.. EVALUATION OF S.. | 1 0.01 96.75 ISHIYAMA Y. A CASE OF MARKED FLUCTUAT.. | 1 0.01 96.76 ISSA N,FISHER W,NARAYANAN J. QT INTER.. | 1 0.01 96.77 IWASAKI M, OKAJIMA K, TAKANO T, MISAK.. | 1 0.01 96.78 IZUMIKAWA M, ET AL.. TWO CASES OF RHE.. | 1 0.01 96.79 JAKOBSEN KD, BRUHN CH, PAGSBERG A, FI.. | 1 0.01 96.80 JAMES A, LARSON T. ACUTE RENAL FAILUR.. | 1 0.01 96.81 JAMES B. MOWRY PHARMD, DANIEL A. SPYK.. | 1 0.01 96.82 JAMES LM, CARNEIRO K. ABNORMAL UTERIN.. | 1 0.01 96.83 JELLINGE M. HEAVY BRADYCARDIA DURING .. | 1 0.01 96.84 JOURNAL OF GASTROINTESTINAL CANCER. P.. | 1 0.01 96.85 K. SHIMIZU, ET AL.. A CASE OF MALIGNA.. | 1 0.01 96.86 KALIKI V, SHALIN SC, EDGAR-ZARATE C A.. | 1 0.01 96.87 KALIKI V, SHALIN SC, EDGAR-ZARATE C. .. | 1 0.01 96.88 KAMANGAR F, BERGER TG, FAZEL N, KOO J.. | 1 0.01 96.89 KANEKO T, KANEKO M. A PATIENT WITH CY.. | 1 0.01 96.90 KANG B, CHOIA S, KIM HS, KIM K, LEE Y.. | 1 0.01 96.91 KANTARJIAN, H.. BOSUTINIB SAFETY AND .. | 2 0.02 96.93 KAPLAN R, MEEHAN SA, LEGER M. A CASE .. | 1 0.01 96.94 KARA I, CELIK JB, APILIOGULLARI S, AY.. | 1 0.01 96.95 KARAM, J.. PHASE 2 TRIAL OF NEOADJUVA.. | 1 0.01 96.96 KARTHIKEYAN VS, SENTHILKUMARAN K, EAS.. | 1 0.01 96.97 KATSUMITSU A, ET AL. EFFECTIVE CASES .. | 1 0.01 96.98 KATZMAN PJ.. NONSYNDROMIC COMPLEX CON.. | 1 0.01 96.99 KAWAI S, SHIGEMATSU Y, ARAKI K ET AL... | 1 0.01 97.00 KAZANCI A, TEKKOK IH. PHENYTOIN INDUC.. | 1 0.01 97.01 KESZTYUS B,CORNISH D. RELAPSING FEVER.. | 1 0.01 97.02 KHOURY T, SCHNEIDER R. CHYLOUS ASCITE.. | 1 0.01 97.03 KIM D, BENJAMIN L, WYSONG A, HOVSEPIA.. | 1 0.01 97.04 KIM JS, KIM DJ, YOU T, JEON JY. DE NO.. | 1 0.01 97.05 KIM KM, KANG G, PARK YS, JUNG ES, JOO.. | 1 0.01 97.06 KIM, H.. LONG-TERM ELECTROPHYSIOLOGIC.. | 1 0.01 97.07 KIMURA Y, ET AL. A CASE OF PSEUDOMEMB.. | 1 0.01 97.08 KITAHARA M, KANEKIYO S, YAMAMOTO T, W.. | 1 0.01 97.09 KITEVA-TRENCHEVSKA GA. PREGNANCY OUTC.. | 3 0.03 97.12 KNOX D, ANDERSON P, HARRIGAN PR, TAN .. | 1 0.01 97.13 KOMAKI C, NIWA T, TATSUOKA H, INOUE Y.. | 1 0.01 97.14 KOMORI K. A CASE OF FULMINANT HEPATIT.. | 1 0.01 97.15 KORKMAZ T, PEKEL N, YESILARAS S, ORAY.. | 1 0.01 97.16 KOSTIC S, PASOVSKI V, KRSMANOVIC Z, B.. | 1 0.01 97.17 KRAJ M, POGLOD R, MAJ S, OWCZARSKA K... | 1 0.01 97.18 KRAJ M, POGLOD R, MAJ S, OWCZARSKA K... | 1 0.01 97.19 KUMAR SS, JAIN N, PRAKASH S, PAWAR M... | 1 0.01 97.20 KUR J, HEMMATI I. ADALIMUMAB-ASSOCIAT.. | 1 0.01 97.21 KURANGI M, USGAONKAR U. GIANT CELL AR.. | 1 0.01 97.22 KUSUMOTO T, KIMURA Y, SUGIYAMA M, OHT.. | 1 0.01 97.23 KUWAHATA S, TAKENAKA T, YASUDA S, SAK.. | 1 0.01 97.24 L. DEL RIO-CASANOVA. VENLAFAXINE-INDU.. | 1 0.01 97.25 L. GRESSIER. ATORVASTATIN-INDUCED DRU.. | 1 0.01 97.26 LAGE R, BICCIGO DG, SANTOS FB, CHIMAR.. | 1 0.01 97.27 LAMBE G, MALVATHU R, THOMAS HM, GRAVE.. | 1 0.01 97.28 LAMPSON BL, YU L, GLYNN RJ, BARRIEN.. | 1 0.01 97.29 LAMPSON BL, YU L, GLYNN RJ, BARRIENT.. | 1 0.01 97.30 LAMPSON BL, YU L, GLYNN RJ, BARRIENTO.. | 1 0.01 97.31 LAMPSON BL, YU L, GLYNN RJ, BARRIENTO.. | 1 0.01 97.32 LAMPSON BL, YU L, GLYNN RJ, BARRIENTO.. | 2 0.02 97.34 LAMPSON BL, YU L, GLYNN RJ, BARRIENTO.. | 1 0.01 97.35 LAMPSON BL, YU L, GLYNN RJ, BARRIENTO.. | 1 0.01 97.36 LAVERGNE R, CHOUAKI T, TOUBLANC B, DU.. | 1 0.01 97.37 LEDUC C.. SUICIDE OF A 57-YEAR-OLD WO.. | 1 0.01 97.38 LEE AJ, MADDIX DS. RHABDOMYOLYSIS SEC.. | 1 0.01 97.39 LEE H, LEE J, SOHN I, PARK S, PARK J,.. | 1 0.01 97.40 LEE H, LEE J, SOHN I, PARK S, PARK J,.. | 2 0.02 97.42 LEE H-Y, HSU Y-C, HSU C-Y, CHOU ECL, .. | 9 0.09 97.51 LEIKIN JB, BRAUND V, DESLAURIS C. CHO.. | 1 0.01 97.52 LEUNG JG, KOODA KJ, FRAZEE EN. NECROT.. | 1 0.01 97.53 LI T, PIPERDI B, WALSH W, KIM M, BECK.. | 1 0.01 97.54 LI X, LIU Y, ZHANG E, HE Q, TANG Y-B... | 1 0.01 97.55 LIEDORP, M.. AXONAL NEUROPATHY WITH P.. | 1 0.01 97.56 LONDHE S P, JOSEPH A, JOHN J, PHILIP .. | 1 0.01 97.57 LOPEZ PARDO P, JIMENEZ ROJAS C, GAMBI.. | 1 0.01 97.58 LYON TD, FERRONI MC, CASELLA DP, D^AG.. | 1 0.01 97.59 MABRY LM, ROSS MD, TONARELLI JM. META.. | 1 0.01 97.60 MAEL H, MOHAMED E, THOMAS X, LE JEUNE.. | 1 0.01 97.61 MALKAN UY, GUNES G, ETGUL S, AKSU S, .. | 1 0.01 97.62 MANCANO M. ISMP ADVERSE DRUG REACTION.. | 1 0.01 97.63 MANCANO M. VIGABATRIN-INDUCED ENCEPHA.. | 1 0.01 97.64 MANINI AF, NELSON LS, SKOLNICK AH, SL.. | 1 0.01 97.65 MANSOUR AM, HUSSEINI ZM, SCHAKAL AR. .. | 1 0.01 97.66 MARR E, HILL D. OPTIMISING SERVICE PR.. | 1 0.01 97.67 MARTIN A, BAILE M, RODRIGUEZ G, DLOUH.. | 1 0.01 97.68 MARTINEZ LOPEZ, A.. IBUPROFEN-INDUCED.. | 3 0.03 97.71 MARTINEZ P, PERDOMO S, ANIBARRO P, PI.. | 1 0.01 97.72 MASAHIRO H. A CASE OF METASTASES TO T.. | 1 0.01 97.73 MASIERO P, OLIVA V, GARCIA M, FERNAND.. | 1 0.01 97.74 MATEOS M, HERNANDEZ M, GIRALDO P, DE .. | 1 0.01 97.75 MATOBA M, FUSHIDA S, OYAMA K, WATANAB.. | 1 0.01 97.76 MAUERMANN, E.. HEPARIN-INDUCED THROMB.. | 1 0.01 97.77 MAURO F, CARELLA A, MOLICA S, PAOLONI.. | 1 0.01 97.78 MAYA Y, FUJITA C, NAKAYAMA C, ET AL. .. | 1 0.01 97.79 MCGRANE IR, SHUMAN MD, MCDONALD RW. D.. | 1 0.01 97.80 MCGRANE IR, SHUMAN MD, MCDONALD RW. D.. | 1 0.01 97.81 MCGRANE IR, SHUMAN MD, MCDONALD RW.. .. | 1 0.01 97.82 MCKAY RR, WERNER L, ZUKOTYNSKI KA, DO.. | 1 0.01 97.83 MEGUMI K, OKUMURA H, SHIMONOSONO M, I.. | 1 0.01 97.84 MEHTA K, WEISS I, GOLDBERG MD.. MEGAC.. | 1 0.01 97.85 MELAMED J, AHUJA-MALIK A. A CASE OF T.. | 1 0.01 97.86 MENA R, SMITH J, GEORGE S, GEILS G AN.. | 1 0.01 97.87 MIKHAEL J. LENALIDOMIDE AND LOW DOSE .. | 1 0.01 97.88 MINAMI K, MORITA M, EMI Y, OKAMOTO M,.. | 1 0.01 97.89 MIYAGAWA E, ET AL. A CASE OF TRANSITI.. | 1 0.01 97.90 MIYAHARA E, ITAGAKI T, KEGOYA Y, KAME.. | 1 0.01 97.91 MIYAMOTO Y, TAKECHI K. A CASE OF RECU.. | 1 0.01 97.92 MOORJANI R, TRUONG TH, LEWIS V, GILCH.. | 1 0.01 97.93 MORICHIKA O, MAEDA T, MISAWA K, IMAI .. | 1 0.01 97.94 MORIO K, IMAMURA M, SHINOHARA M, NA.. | 1 0.01 97.95 MORIO K, IMAMURA M, KAWAKAMI Y, MORIO.. | 1 0.01 97.96 MOTOHASHI Y. TAKOTSUBO CARDIOMYOPATHY.. | 1 0.01 97.97 MOWRY JB, SPYKER DA, BROOKS DE, MCMIL.. | 1 0.01 97.98 MOWRY JB, SPYKER DA, CANTILENA JR. LR.. | 2 0.02 98.00 MOWRY, J.. 2012 ANNUAL REPORT OF THE .. | 1 0.01 98.01 MUDONI A, CACCETTA F, CAROPPO M, MUSI.. | 8 0.08 98.09 MURAKAMI Y, HATTORI S, SUGIYAMA F, YO.. | 1 0.01 98.10 MURASAWA M, SAKURADA T, OISHI D, SUZU.. | 1 0.01 98.11 N CALVERT, D WOOD, ET AL. USE OF DENO.. | 1 0.01 98.12 NAGANUMA M, SHIGA T, NAGAO T, SUZUKI .. | 1 0.01 98.13 NAGASHIMA S. EFFECTIVENESS OF LENVATI.. | 1 0.01 98.14 NAKAMURA Y, KAMEI T, SHINAGAWA M, SAK.. | 1 0.01 98.15 NAOMI A, OYAMATSU Y, NARITA K, NAKAYA.. | 1 0.01 98.16 NASA P, SINGH A, JUNEJA D, SINGH O, J.. | 1 0.01 98.17 NASEER M, SABBAGH H, JANDALI MA, KULA.. | 1 0.01 98.18 NEMOTO H, TATE G, UMEMOTO T, MATSUBAR.. | 1 0.01 98.19 NEVILLE D, SCOTT M, BHUPINDER S, SARA.. | 1 0.01 98.20 NEWCOMER JW, PIKALOV A, WATABE K, CUC.. | 1 0.01 98.21 NGUYEN R, BRAUE A, BAKER CS, FOLEY PA.. | 1 0.01 98.22 NIKOLAOU M, SALOUSTROS E, POLYZOS A, .. | 1 0.01 98.23 NISHIKAWA K, ET AL. TWO CASES OF ENHA.. | 1 0.01 98.24 NISHIMURA Y, TANAKA H, OKABE Y, TSUJI.. | 1 0.01 98.25 NO INFORMATION. VARIOUS TOXICITIES: 3.. | 1 0.01 98.26 NODA S, KASHIWAGI S, KAWAJIRI H, TAKA.. | 1 0.01 98.27 NOGUERA A, BALLESTA P, BAEZA I, ARANG.. | 1 0.01 98.28 NORDGAARD, J.. PREGABALIN CAN CAUSE A.. | 1 0.01 98.29 NORIHIDE FUKUSHIMA ET AL. EXPERIENCE .. | 1 0.01 98.30 ODAJIMA H, HIROSHI ODAJIMA LONG-TERM .. | 1 0.01 98.31 OGIWARA Y, YAMADA N, AKIMASA, MATSUDA.. | 1 0.01 98.32 OKAMOTO M, TSUTSUMI K, ITO T, KASHIMA.. | 1 0.01 98.33 OO MT. ACUTE DYSTONIC REACTIONS IN A .. | 1 0.01 98.34 OO Y, PACKHAM D, YAU W, MUNCKHOF W. E.. | 1 0.01 98.35 ORIOLO G, BARBOSA L, IMAZ ML, GARCIA .. | 1 0.01 98.36 OTUKA, K.. EFFICACY OF TACROLIMUS COM.. | 1 0.01 98.37 OU S, GOVINDAN R, EATON K, OTTERSON G.. | 1 0.01 98.38 OUAHED J, THIAGARAJAH J, RUFO P, RIVK.. | 1 0.01 98.39 OUCHI A, OUCHI A, ASANO M, AONO K, WA.. | 1 0.01 98.40 OZCETE E, UZ I, KIYAN S. CARDIAC ARRE.. | 1 0.01 98.41 PALLADINI G, MILANI P, FOLI A, BASSET.. | 1 0.01 98.42 PAN Z, YANG G, HE H, DONG L. CONCURRE.. | 1 0.01 98.43 PANACCIONE R, GHOSH S, MIDDLETON S, M.. | 1 0.01 98.44 PARDO P,ROJAS C,MURO G,CAMACHO M. LEV.. | 1 0.01 98.45 PARK W, YOO DH, JAWORSKI J, BRZEZICKI.. | 1 0.01 98.46 PARSAI, S.. A LITERATURE REVIEW REVIS.. | 1 0.01 98.47 PATIL MM, SAHOO J, KAMALANATHAN S, PI.. | 1 0.01 98.48 PATRICK WILTON, MD, PHD, ANDERS F. MA.. | 1 0.01 98.49 PATRICK WILTON, MD, PHD, ANDERS F. MA.. | 1 0.01 98.50 PATRICK WILTON. GROWTH HORMONE TREATM.. | 1 0.01 98.51 PAVLAKIS P, DOUGLASS L. PEARLS AND OY.. | 1 0.01 98.52 PAVLIS MB, LIEBLICH L. ISOTRETINOIN-I.. | 1 0.01 98.53 PENKERT H, DELBRIDGE C, WANTIA N, ET .. | 1 0.01 98.54 PEREZ-SABORIDO B, ASENSIO-DIAZ E, BAR.. | 1 0.01 98.55 PERLIN, DMITRY. EVEROLIMUS FOR KAPOSI.. | 1 0.01 98.56 PHILLIPS BN, CHUN DW. HYDROXYCHLOROQU.. | 1 0.01 98.57 PILANCI, K.. A RARE CASE OF SUNITINIB.. | 1 0.01 98.58 PISTACCHI M, GIOULIS M, ZIRILLO M, FR.. | 1 0.01 98.59 PLEYER L, DOHNER H, DOMBRET H, SEYMOU.. | 1 0.01 98.60 PODDUBNAYA I, BABICHEVA L, KAPLANOV K.. | 1 0.01 98.61 PONZETTI A, PINTA F, SPADI R, MECCA C.. | 1 0.01 98.62 POOLE A, TANTRAVAHI SK, GIRARD N, CL.. | 1 0.01 98.63 POPAL S, VERBAAN BW, VREEBURG GCM, RA.. | 1 0.01 98.64 POUDEL RR, KAFLE NK. TIZANIDINE-INDUC.. | 1 0.01 98.65 POWELL JB, MATTHEWS P, RATTEHALI R, W.. | 1 0.01 98.66 PROSPERINI L, DE ROSSI N, SCARPAZZA C.. | 1 0.01 98.67 PROSPERINI L, DE ROSSI N, SCARPAZZA C.. | 2 0.02 98.69 PROSPERINI L, DE ROSSI N, SCARPAZZA C.. | 1 0.01 98.70 PROSPERINI L. PROSPERINI, L, DE ROSSI.. | 1 0.01 98.71 PROSPERINI L. PROSPERINI, L, DE ROSSI.. | 1 0.01 98.72 QANNETA R, PI I SANCHEZ J, MARTI TRIG.. | 1 0.01 98.73 RABAH F, BESHLAWI I, EL-NAGGARI M, AL.. | 1 0.01 98.74 RAJA M, SILVIA R. LITHIUM TREATMENT I.. | 1 0.01 98.75 RALAPANAWA DM, KULARATNE SA. KOUNIS S.. | 1 0.01 98.76 RAMIREZ HUARANGA MA, RAMOS RODRIGUEZ .. | 1 0.01 98.77 ROCHE L, LYNCH M, AHMAD K, HACKETT .. | 1 0.01 98.78 ROCHMAH N, MARZUKI NS, AGUSTIARINI E,.. | 2 0.02 98.80 RODRIGUES DE CARVALHO T. G., SILVA J... | 1 0.01 98.81 RODRIGUES DE CARVALHO T. G., SILVA J... | 2 0.02 98.83 RODRIGUES T, SILVA J, PINTO R, DINIS .. | 1 0.01 98.84 ROMAN C, SLAMA TG. ACUTE RENAL FAILUR.. | 1 0.01 98.85 ROSENTAL A, DUECK A, ANSELL S, GANO K.. | 1 0.01 98.86 ROSENTHAL A. A PHASE 2 STUDY OF LENAL.. | 1 0.01 98.87 ROSENTHAL A. A PHASE 2 STUDY OF LENAL.. | 1 0.01 98.88 RUDA R, BOSA C, MAGISTRELLO M, FRANCH.. | 2 0.02 98.90 SACHDEVA A, RATHEE R. AKATHISIA WITH .. | 1 0.01 98.91 SAFAK T, KARABULUT AE, CORBACIOGLU SK.. | 1 0.01 98.92 SAGUEM BN, BOUHLEL S, BEN SALEM C, BE.. | 1 0.01 98.93 SAKATA R, IWASAKI A, KOBAYASHI M, OSA.. | 1 0.01 98.94 SALTZ L, INFANTE J, SCHWARTZBERG L, S.. | 1 0.01 98.95 SAMMUT L, WALLIS D, HOLROYD C. PROGRE.. | 1 0.01 98.96 SASAKI ET AL.. A CASE IN WHICH BOTH S.. | 1 0.01 98.97 SASAKI K, KANTARJIAN H, O^BRIEN S, TH.. | 2 0.02 98.99 SATSANGI JL, FASCI-SPURIO F, THOMPSON.. | 1 0.01 99.00 SEFERYNSKA I, WARZOCHA K. SUCCESSFUL .. | 1 0.01 99.01 SENO H, KOMASAWA N, HASWGAWA Y, KUSAK.. | 1 0.01 99.02 SEPPALA H, VIRTANEN E, SAARELA M, LAI.. | 1 0.01 99.03 SESSA M, RAFANIELLO C, SPORTIELLO L, .. | 1 0.01 99.04 SHAH N, SHAH N. PHASE I/II TRIAL OF L.. | 1 0.01 99.05 SHARMAN JP, FARBER CM, MAHADEVAN D, S.. | 1 0.01 99.06 SHIBASAKI M, TANABE A, TODA T, SAKATA.. | 1 0.01 99.07 SHUAIB W,BEATRICE C,ABAZID A. ZOLPIDE.. | 1 0.01 99.08 SIAU K, VARUGHESE M. THROMBOTIC MICRO.. | 1 0.01 99.09 SIKOV W. EFFICACY AND TOLERABILITY OF.. | 1 0.01 99.10 SIMALTI AK. PSEUDOTUMOUR CEREBRI: A S.. | 1 0.01 99.11 SIVILOTTI MLA, JUURLINK DN, GARLAND J.. | 3 0.03 99.14 SNYDER A. COMMENT ON: FAILURE OF COMB.. | 1 0.01 99.15 SNYDER, M.. SERTRALINE-INDUCED RHABDO.. | 1 0.01 99.16 SOHEI, F. ET AL.. KINKI REGIONAL MEET.. | 1 0.01 99.17 SOLLA P, CANNAS A, CONGIA S, FLORIS G.. | 1 0.01 99.18 SOLLA P, CANNAS A, CORONA M, MARROSU .. | 2 0.02 99.20 SONE S, YOSHINO A, KAWAHARA Y ET AL.... | 1 0.01 99.21 SOON WC, WEST K, GIBEON D, BOWEN EF. .. | 1 0.01 99.22 SPINDELEGGER CJ, PAPAGEORGIOU K, GROH.. | 1 0.01 99.23 STASSINOS G,GONZALES L,KLEIN-SCHWARTZ.. | 1 0.01 99.24 STASSINOS GL, GONZALES L, KLEIN-SCHWA.. | 1 0.01 99.25 STOHR W, ODDERSHEDE L, ARENAS-PINTO .. | 1 0.01 99.26 STRAIN W, LYE M. CHRONIC PAIN, BEREAV.. | 1 0.01 99.27 STRATI P, SHANAFELT T, LAPLANT B, PET.. | 1 0.01 99.28 SU CW, MCKAY B. TREATMENT OF HSV INFE.. | 1 0.01 99.29 SUKAWA Y, NOSHO K, MIURA Y, TAKANO T,.. | 1 0.01 99.30 SUNAZAWA T, NAKAYA M, OOTSU M, WAKABA.. | 1 0.01 99.31 SUONPAA P, VIRTANEN E, SAARELA M, LAI.. | 1 0.01 99.32 SUZUKI K. ONE CASE OF GASTROINTESTINA.. | 2 0.02 99.34 SWAIN SM. NSABP B-38: DEFINITIVE ANAL.. | 1 0.01 99.35 SWAIN SM. NSABP B-38: DEFINITIVE ANAL.. | 1 0.01 99.36 SWORDS R. RESULTS OF A CLINICAL STUDY.. | 1 0.01 99.37 SYLVIA MT, RANI J, BASU D, KAR R, DUB.. | 1 0.01 99.38 TAKEDA K. EFFORTS TO CONTROL SIDE EFF.. | 1 0.01 99.39 TAKEUCHI Y, KITABAYASHI C, YAMAZAKI D.. | 1 0.01 99.40 TAOKA N. A CASE WITH AUTOIMMUNE HEPAT.. | 1 0.01 99.41 TARDY-PONCET, B.. ARGATROBAN IN THE M.. | 2 0.02 99.43 TAZAWA K. P1-047 THREE CASES OF GASTR.. | 1 0.01 99.44 TEMSIROLIMUS: RIQUE D^INFARCTUS DU MY.. | 2 0.02 99.46 TERAKAWA H, OYAMA K, WATANABE T, TSUK.. | 1 0.01 99.47 TERASHIMA T. A CASE OF ABUSE OF FENTA.. | 1 0.01 99.48 THOMPSON G, PEPPERELL D, LAWRENCE I, .. | 1 0.01 99.49 THOMPSON, T.. HOIGNE SYNDROME: A LITT.. | 1 0.01 99.50 TOFANI C, GANDHI K, HALEGOUA-DEMARZIO.. | 1 0.01 99.51 TOSCANO G, FABOZZO A, FEDRIGO M, GAMB.. | 1 0.01 99.52 TOYOTA S, SUGIURA S AND IWAISAKO K. S.. | 1 0.01 99.53 TOYOTA S, SUGIURA S AND IWAISAKO K. S.. | 1 0.01 99.54 TOYOTA S, SUGIURA S AND IWAISAKO K. S.. | 1 0.01 99.55 TREUMER F, WIENAND S. PURTSKHVANIDZE .. | 1 0.01 99.56 TRIPLE PARADOXICAL REACTION DUE TO AD.. | 1 0.01 99.57 TRUSSON R, SERRE JE, SZWARC I, DELMAS.. | 1 0.01 99.58 TSUKAMOTO K, AJIRO Y, HASEGAWA S, WAT.. | 1 0.01 99.59 TSUTSUMI R. ONE CASE OF DRUG-INDUCED .. | 1 0.01 99.60 UCLER R, ATMACA M, CANDAR O, ALAY M, .. | 1 0.01 99.61 UEMURA H, OKA Y, OKADA K, OHMURA Y, N.. | 1 0.01 99.62 UNKNOWN. TEMSIROLIMUS: RISK OF MYOCAR.. | 1 0.01 99.63 UPRETY D, BABER A, FOY M. KETAMINE IN.. | 1 0.01 99.64 URABE A. STUDY OF THE THERAPEUTIC EFF.. | 1 0.01 99.65 USLU FI, ERDEM NS, YAGAN S. A CASE WI.. | 1 0.01 99.66 VARGHA R, MOSTAFA G, BURDA G, HERMON .. | 1 0.01 99.67 VAROTTI, C. AMIODARONE-INDUCED PIGMEN.. | 1 0.01 99.68 VOSKO M, BOCKSRUCKER C, DRWILA R, DUL.. | 1 0.01 99.69 WADA M. A CASE OF CHRONIC THYROIDITIS.. | 1 0.01 99.70 WALLACE IR, WATERS NH, PILMORE H, DRU.. | 1 0.01 99.71 WALLACE, D.. EFFICACY AND SAFETY OF A.. | 1 0.01 99.72 WARKENTIN, T.. HOW I TREAT PATIENTS W.. | 1 0.01 99.73 WATANABE S, KANEKO Y, KAWAMOTO H, ET .. | 1 0.01 99.74 WATANABE, A.. A CASE OF STEVENS-JOHNS.. | 1 0.01 99.75 WEISE, A.M.. FATAL LIVER FAILURE IN A.. | 1 0.01 99.76 WILLIAMS RF, HOANG MP, KROSHINSKY D, .. | 1 0.01 99.77 WILTON, P.. GROWTH HORMONE TREATMENT .. | 1 0.01 99.78 WITHEY S, TAMIMI A. SPONTANEOUS PULMO.. | 1 0.01 99.79 WITTER D, MCCORD M, SURYADEVARA U. DE.. | 1 0.01 99.80 WITTMANN O, SADOT E, BISKER-KASSIF O,.. | 1 0.01 99.81 WITZENS-HARIG, M.. SAFETY AND CLINICA.. | 1 0.01 99.82 WONG L, ORLOFF S. URGENT LIVER TRANSP.. | 1 0.01 99.83 WUTTE N,PALFNER M,PALFNER M. TOXOCARO.. | 1 0.01 99.84 WYSOKINSKI A. PERSISTENT PENILE ERECT.. | 1 0.01 99.85 XU C, RICCIUTI A, CATUREGLI P, KEENE .. | 1 0.01 99.86 YAMADA R, OHARA J, NAKAJIMA M, HORII .. | 1 0.01 99.87 YAMADA T, KANAZAWA Y, YOKOI K, UCHIDA.. | 1 0.01 99.88 YAMADA, M., KURODA, H., YOSHIDA. M., .. | 1 0.01 99.89 YAMANA T. A CASE OF SMALL CELL LUNG C.. | 1 0.01 99.90 YAU M, RAO N, NIMKARN S, VOGIATZI M. .. | 1 0.01 99.91 YENENEH B. IVABRADINE^S POTENT EFFECT.. | 1 0.01 99.92 YOO D, HRYCAJ P, MIRANDA P, RAMITERRE.. | 1 0.01 99.93 YOO DH, RACEWICZ A, BRZEZICKI J, YATS.. | 1 0.01 99.94 ZAJA F, FERRARI A, STELITANO C, SALVI.. | 1 0.01 99.95 ZEUZEM S,FLISIAK R,VIERLING J,MAZUR W.. | 2 0.02 99.97 ZHU JM, HAMEL D, DHALIWAL G, GLASS M,.. | 1 0.01 99.98 ZIEG J, HACEK J.. ORAL PENICILLIN ASS.. | 1 0.01 99.99 ZYCHOWSKA M, BATYCKA-BARAN A, BARAN W.. | 1 0.01 100.00 ----------------------------------------+----------------------------------- Total | 10,000 100.00 by Jean Roth , jroth@nber.org , 18 Sep 2017